Thermo-Responsive, Inflammation-Targeting (TRIT) Hydrogel Formulations for Local Drug Delivery in Intestinal Inflammation
This technology introduces innovative solutions for targeted drug delivery, particularly focusing on thermoresponsive hydrogel polymers. These formulations incorporate thermoresponsive hydrogel polymers containing releasable therapeutic agents, offering a unique blend of characteristics, including mechanical strength, biocompatibility, thermal responsiveness, and precise drug delivery configurations. The compositions can include a sol-to-gel transition system under physiological conditions, comprising nanoparticles and thermoresponsive polymers with attached ligands. In the medical context, this technology addresses the need for improved drug delivery in conditions such as Ulcerative Colitis, ensuring more effective and precise treatment.
Researchers
-
compositions and related methods for targeted drug delivery
United States of America | Granted | 11,684,583
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.